CareDx (CDNA) Tops Q1 EPS by 21c; Withdraws Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.11), $0.21 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $77.26 million versus the consensus estimate of $80.7 million.

GUIDANCE:

CareDx is withdrawing 2023 revenue guidance at this time given a multitude of unknown variables related to the March and May 2023 Billing Article revisions.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• AMD joins $1 trillion club as chipmakers rally on AI-driven demand
• Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M